Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
Manage episode 289048769 series 2898408
In this episode, Alan G. Minsk, partner and leader of the Food & Drug practice team, is joined by Brian A. Teras, partner of the Corporate & Securities practice team. They provide an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process.
9 つのエピソード